227 related articles for article (PubMed ID: 37264655)
1. Recent Advancements in Novel Formulations of Anti-psoriatic Agents for Effective Delivery: Clinical Importance and Patent Survey.
Dadwal N; Kurmi BD; Singh D; Singh A
Recent Pat Nanotechnol; 2024; 18(3):259-277. PubMed ID: 37264655
[TBL] [Abstract][Full Text] [Related]
2. Role of Apoptotic-targeted Phytoconstitutent-loaded Antipsoriatic Nanobiocomposites.
Singh Patel P; Srivastava R; Panchawat S
Recent Pat Nanotechnol; 2024; 18(2):220-236. PubMed ID: 36725825
[TBL] [Abstract][Full Text] [Related]
3. Understanding the prospective of nano-formulations towards the treatment of psoriasis.
Pradhan M; Alexander A; Singh MR; Singh D; Saraf S; Saraf S; Ajazuddin
Biomed Pharmacother; 2018 Nov; 107():447-463. PubMed ID: 30103117
[TBL] [Abstract][Full Text] [Related]
4. An Overview on Promising Nanotechnological Approaches for the Treatment of Psoriasis.
Pandey K; Nimisha
Recent Pat Nanotechnol; 2020; 14(2):102-118. PubMed ID: 32013854
[TBL] [Abstract][Full Text] [Related]
5. Nanomedicine-based drug targeting for psoriasis: potentials and emerging trends in nanoscale pharmacotherapy.
Rahman M; Akhter S; Ahmad J; Ahmad MZ; Beg S; Ahmad FJ
Expert Opin Drug Deliv; 2015 Apr; 12(4):635-52. PubMed ID: 25439967
[TBL] [Abstract][Full Text] [Related]
6. A Promising Approach of Dermal Targeting of Antipsoriatic Drugs
Tripathi D; Srivastava M; Rathour K; Rai AK; Wal P; Sahoo J; Tiwari RK; Pandey P
Drug Metab Bioanal Lett; 2023; 16(2):89-104. PubMed ID: 37534794
[TBL] [Abstract][Full Text] [Related]
7. Nanocarriers Mediated Topical Drug Delivery for Psoriasis Treatment.
Gungor S; Rezigue M
Curr Drug Metab; 2017; 18(5):454-468. PubMed ID: 28228078
[TBL] [Abstract][Full Text] [Related]
8. Current and Future Therapies for Psoriasis with a Focus on Serotonergic Drugs.
Martins AM; Ascenso A; Ribeiro HM; Marto J
Mol Neurobiol; 2020 May; 57(5):2391-2419. PubMed ID: 32062841
[TBL] [Abstract][Full Text] [Related]
9. Advances in psoriasis physiopathology and treatments: Up to date of mechanistic insights and perspectives of novel therapies based on innovative skin drug delivery systems (ISDDS).
Sala M; Elaissari A; Fessi H
J Control Release; 2016 Oct; 239():182-202. PubMed ID: 27381248
[TBL] [Abstract][Full Text] [Related]
10. Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.
Sbidian E; Chaimani A; Afach S; Doney L; Dressler C; Hua C; Mazaud C; Phan C; Hughes C; Riddle D; Naldi L; Garcia-Doval I; Le Cleach L
Cochrane Database Syst Rev; 2020 Jan; 1(1):CD011535. PubMed ID: 31917873
[TBL] [Abstract][Full Text] [Related]
11. Ultraviolet Phototherapy Management of Moderate-to-Severe Plaque Psoriasis: An Evidence-Based Analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2009; 9(27):1-66. PubMed ID: 23074532
[TBL] [Abstract][Full Text] [Related]
12. Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.
Sbidian E; Chaimani A; Garcia-Doval I; Doney L; Dressler C; Hua C; Hughes C; Naldi L; Afach S; Le Cleach L
Cochrane Database Syst Rev; 2021 Apr; 4(4):CD011535. PubMed ID: 33871055
[TBL] [Abstract][Full Text] [Related]
13. Treatment Modalities of Psoriasis: A Focus on Requisite for Topical Nanocarrier.
Ramanunny AK; Wadhwa S; Thakur D; Singh SK; Kumar R
Endocr Metab Immune Disord Drug Targets; 2021; 21(3):418-433. PubMed ID: 32496998
[TBL] [Abstract][Full Text] [Related]
14. Nanotechnology-based Medicinal Products and Patents: A Promising Way to Treat Psoriasis.
Ali F; Neha K; Sharma K; Khasimbi S; Chauhan G
Curr Drug Deliv; 2022; 19(5):587-599. PubMed ID: 35081890
[TBL] [Abstract][Full Text] [Related]
15. Biosimilars in psoriasis: the future or not?
Kellen R; Goldenberg G
Cutis; 2017 Feb; 99(2):116-120. PubMed ID: 28319617
[TBL] [Abstract][Full Text] [Related]
16. Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.
Sbidian E; Chaimani A; Garcia-Doval I; Do G; Hua C; Mazaud C; Droitcourt C; Hughes C; Ingram JR; Naldi L; Chosidow O; Le Cleach L
Cochrane Database Syst Rev; 2017 Dec; 12(12):CD011535. PubMed ID: 29271481
[TBL] [Abstract][Full Text] [Related]
17. Antipsoriatic drug development: challenges and new emerging therapies.
García-Pérez ME; Jean J; Pouliot R
Recent Pat Inflamm Allergy Drug Discov; 2012 Jan; 6(1):3-21. PubMed ID: 22022925
[TBL] [Abstract][Full Text] [Related]
18. Novel drug delivery systems in topical treatment of psoriasis: rigors and vigors.
Katare OP; Raza K; Singh B; Dogra S
Indian J Dermatol Venereol Leprol; 2010; 76(6):612-21. PubMed ID: 21079304
[TBL] [Abstract][Full Text] [Related]
19. Current Insights for the Management of Acne in the Modern Era.
Singh N; Singh A; Pandey K; Nimisha
Recent Pat Antiinfect Drug Discov; 2020; 15(1):3-29. PubMed ID: 32729430
[TBL] [Abstract][Full Text] [Related]
20. Nanotechnology-based alternatives for the topical delivery of immunosuppressive agents in psoriasis.
Gomes GS; Frank LA; Contri RV; Longhi MS; Pohlmann AR; Guterres SS
Int J Pharm; 2023 Jan; 631():122535. PubMed ID: 36566826
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
